Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy

다국어 초록 (Multilingual Abstract)

Background and Objectives: Preimplantation QRS-T morphology screening (TMS) is a composite tool for selecting subcutaneous implantable cardioverter defibrillator (S-ICD) candidates. However, its role in predicting the patient's response to cardiac resynchronization therapy (CRT) is uncertain.
Methods: A total of 55 consecutive de novo CRT candidates were enrolled between January 2016 and March 2017. Electrocardiogram (ECG) and TMS were performed before and soon after implantation. The ECG parameters were recorded, including QRS duration and morphology (such as ΔQRS_Index, QTc during biventricular pacing mode [BiV pacing QTc], and QRS/T ratio during biventricular pacing mode [BiV pacing QRS/T ratio]). TMS monitored three sensory vectors of the S-ICD. Six months after implantation, the responses to CRT were evaluated.
Results: Thirty-nine patients (70.9%) passed the TMS during biventricular pacing mode. At the six-month follow-up, the number of responders and super-responders was significantly higher in the passing group than in the non-passing group (responders: 31/39 [79.5%] vs. 5/16 [31.3%], p<0.001; super-responders: 9/39 [23.1%] vs. 1/16 [6.3%], p=0.020). The super-response rate was higher among patients who passed all three vectors than among those who passed 1 or 2 vectors (3 vs. 2 vectors, p=0.018; 3 vs. 1 vector, p=0.003). A smaller left atrial diameter, vectors that passed TMS during biventricular pacing mode, and larger ΔQRS_Index values were independently associated with good CRT response.
Conclusions: Our study demonstrated that patients on CRT who pass the TMS during biventricular pacing mode are more likely to respond and super-respond to CRT.

참고문헌 (Reference)

1 Olde Nordkamp LR, "Which patients are not suitable for a subcutaneous ICD : incidence and predictors of failed QRS-T-wave morphology screening" 25 : 494-499, 2014

2 Groh CA, "Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator" 11 : 1361-1366, 2014

3 Bacharova L, "The role of ECG in the diagnosis of left ventricular hypertrophy" 10 : 257-261, 2014

4 Hiraiwa H, "The Selvester QRS score as a predictor of cardiac events in nonischemic dilated cardiomyopathy" 71 : 284-290, 2018

5 Zeb M, "Sensitivity and specificity of the subcutaneous implantable cardioverter defibrillator pre-implant screening tool" 195 : 205-209, 2015

6 Burke MC, "Safety and efficacy of the totally subcutaneous implantable defibrillator : 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry" 65 : 1605-1615, 2015

7 Guo JP, "Role of electrocardiogram in predicting cardiac resynchronization therapy response" 44 : 483-488, 2016

8 Lang RM, "Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging" 16 : 233-270, 2015

9 Rickard J, "QRS narrowing is associated with reverse remodeling in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy" 10 : 55-60, 2013

10 van Stipdonk AM, "QRS area is a strong determinant of outcome in cardiac resynchronization therapy" 11 : e006497-, 2018

11 Hsu JC, "Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome : the MADIT-CRT(multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy)study" 59 : 2366-2373, 2012

12 Killu AM, "Predictors and outcomes of"super-response"to cardiac resynchronization therapy" 20 : 379-386, 2014

13 Hadjis A, "Predicting response to cardiac resynchronization therapy : use of strict left bundle branch block criteria" 42 : 431-438, 2019

14 Brouwer TF, "Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy" 68 : 2047-2055, 2016

15 Kuperstein R, "Left atrial volume and the benefit of cardiac resynchronization therapy in the MADIT-CRT trial" 7 : 154-160, 2014

16 Burri H, "Iterative method for atrioventricular optimization of cardiac resynchronization therapy: is beauty only in the eye of the beholder?" 16 : 1865-1866, 2014

17 António N, "Identification of ‘super-responders’ to cardiac resynchronization therapy : the importance of symptom duration and left ventricular geometry" 11 : 343-349, 2009

18 Randles DA, "How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?" 16 : 1015-1021, 2014

19 Cai C, "High sensitivity C-reactive protein and cardfiac resynchronization therapy in patients with advanced heart failure" 11 : 296-302, 2014

20 Ip JE, "Eligibility of pacemaker patients for subcutaneous implantable cardioverter defibrillators" 28 : 544-548, 2017

21 Ziacchi M, "Electrocardiographic eligibility for subcutaneous implantable cardioverter defibrillator : evaluation during bicycle exercise" 25 : 476-483, 2016

22 Chalil S, "Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy" 30 : 1201-1209, 2007

23 Xue C, "Effect of cardiac resynchronization therapy in patients with dispersion of repolarization and ventricular arrhythmia" 31 : 250-253, 2016

24 Yanagisawa S, "Clinical characteristics and predictors of super-response to cardiac resynchronization therapy : a combination of predictive factors" 37 : 1553-1564, 2014

25 Kawabata M, "Candidacy for a subcutaneous implantable cardioverter defibrillator in patients with cardiac resynchronization therapy" 59 : 951-958, 2018

26 Fontaine JM, "Biventricular paced QRS predictors of left ventricular lead locations in relation to mortality in cardiac resynchronization therapy" 48 : 226-235, 2015

27 Fujinami M, "Association between the baseline peripheral blood monocyte counts, the size of spleen, and the response to cardiac resynchronization therapy" 71 : 299-304, 2018

28 Corbalan R, "Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation : a report from the GARFIELD-AF registry" 4 : 526-548, 2019

29 Ponikowski P, "2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure" 69 : 1167-, 2016